• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Friday, April 23, 2021
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Olfactory receptors: New molecular targets detected in colorectal cancer cells

Bioengineer by Bioengineer
March 23, 2017
in Science News
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: RUB, Marquard

Growth of colorectal cancer cells can be inhibited with the odorant troenan. This is reported by the research team headed by Prof Dr Dr Dr habil. Hanns Hatt and Dr Lea Weber from Ruhr-Universität Bochum in the journal PLOS ONE. The researchers detected the olfactory receptor OR51B4 in tumour cells taken from the rectum and colon cancer cell lines. They analysed which odorant activates the receptor and in what way the activation affects the cells.

For the purpose of the study, the team from the Department for Cellphysiology in Bochum collaborated with the Department of Molecular GI-Oncology at Ruhr-Universität, headed by Prof Dr Stephan Hahn. The necessary gene sequencing was carried out by the team from the Cologne Center for Genomics.

Floral scent activates receptor

Olfactory receptors had been demonstrated in various healthy as well as cancerous tissues. The Bochum-based researchers have now detected the OR51B4 receptor (upregulated) in colorectal cancer cells. They identified the molecule troenan as activator of OR51B4. It smells of privet, a flowering shrub that is often cultivated in hedges.

In the next step, the researchers treated cancerous cells of the HCT116 cell line and tumour tissue samples with troenan. The result: cell proliferation was slowed down and the cells moved more slowly than previously – an inhibition of tumour growth and metastasis. Moreover, troenan treatment resulted in an increase in apoptosis of cancerous cells. In follow-up experiments with nude mice, which grew the human tumour, the scent effect has been confirmed.

Potential therapy approach

Colorectal cancer is the second most common cancer form in Germany, occurring in more than six per cent of all Germans. The material utilised in the current study were colorectal tumours, which amount to 95 per cent of malign rectal tumours and constitute the most frequent cause of death in colorectal cancer patients. After surgical removal of such tumours, patients have a chance of recovery of 50 per cent. The decisive factor is the stage of the disease in which colorectal cancer is detected. Specific pharmacological treatment is, as yet, not available; only general chemotherapy.

"We assume that our results might pave the way for a new approach for colorectal cancer therapy," says Hanns Hatt. The tumours can often be accessed from the inner cavity of the intestine. "It is therefore conceivable that oral or rectal administration might transport the scent troenan in effective concentrations directly to the tumour. To this end, it will be necessary to conduct clinical studies with patients," continues Hatt.

###

Media Contact

Hanns Hatt
[email protected]
49-234-322-4586
@ruhrunibochum

http://www.ruhr-uni-bochum.de

############

Story Source: Materials provided by Scienmag

Share12Tweet7Share2ShareShareShare1

Related Posts

IMAGE

Successful research development approach helps cancer patients using mobile tech

April 22, 2021
IMAGE

Army-funded research paves way for improved lasers, communications

April 22, 2021

Silver ions hurry up, then wait as they disperse

April 22, 2021

C-Path opens access to Duchenne Regulatory Science Consortium database

April 22, 2021

Leave a Reply Cancel reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

POPULAR NEWS

  • IMAGE

    A sturdier spike protein explains the faster spread of coronavirus variants

    45 shares
    Share 18 Tweet 11
  • New evidence in search for the mysterious Denisovans

    34 shares
    Share 14 Tweet 9
  • Jonathan Wall receives $1.79 million to develop new amyloidosis treatment

    61 shares
    Share 24 Tweet 15
  • UofL, Medtronic to develop epidural stimulation algorithms for spinal cord injury

    56 shares
    Share 22 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

WeaponryVirologyVehiclesZoology/Veterinary ScienceUrbanizationVirusVaccineVaccinesWeather/StormsUrogenital SystemUniversity of WashingtonViolence/Criminals

Recent Posts

  • Successful research development approach helps cancer patients using mobile tech
  • Army-funded research paves way for improved lasers, communications
  • Silver ions hurry up, then wait as they disperse
  • C-Path opens access to Duchenne Regulatory Science Consortium database
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In